BELLUS Health, Inc. (NASDAQ: BLUS), a global health company, is committed to developing and commercializing products that provide innovative health solutions to address substantial, but unmet needs. The company’s wholly owned subsidiary, OVOS Natural Health Inc., aims to develop a strong franchise with several products marketed to help brain function as well as expand to other conditions. For further information, visit the Company’s web site at www.bellushealth.com.
- 17 years ago
QualityStocks
BELLUS Health, Inc. (NASDAQ: BLUS)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Q2 2025 Results Show Record First-Half Profitability, Strong U.S. Contract Wins
SuperCom (NASDAQ: SPCB), a global provider of secured e-Government, IoT, and cybersecurity solutions, reported Q2…
-
QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Present at Webull Financial Biotech/MedTech Webinar Series
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharma company developing novel treatments for primary and metastatic cancers…
-
QualityStocksNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Showcases Emergency Command Platform at Indonesia Disaster Expo
FingerMotion (NASDAQ: FNGR) announced that its subsidiary, Shanghai JiuGe Information Technology Co., Ltd., is presenting…